Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, November 25, 2023

Transcranial direct current stimulation inhibits epileptic activity propagation in a large-scale brain network model

 With your chance of seizures and epilepsy post stroke, is your doctor prepared with this intervention?

Do you prefer your  doctor and hospital incompetence NOT KNOWING? OR NOT DOING?

 

Transcranial direct current stimulation inhibits epileptic activity propagation in a large-scale brain network model

Abstract

Transcranial direct current stimulation (tDCS) is a noninvasive technique that uses constant, low-intensity direct current to regulate brain activities. Clinical studies have shown that cathode-tDCS (c-tDCS) is effective in reducing seizure frequency in patients with epilepsy. Due to the heterogeneity and patient specificity of seizures, patient-specific epilepsy networks are increasingly important in exploring the regulatory role of c-tDCS. In this study, we first set the left hippocampus, para-hippocampus, and amygdala as the epileptogenic zone (EZ), and the left inferior temporal cortex and ventral temporal cortex as the initial propagation zone (PZ) to establish a large-scale epilepsy network model. Then we set tDCS cathode locations according to the maximum average energy of the simulated EEG signals and systematically study c-tDCS inhibitory effects on the propagation of epileptic activity. The results show that c-tDCS is effective in suppressing the propagation of epileptic activity. Further, to consider the patient specificity, we set specific EZ and PZ according to the clinical diagnosis of 6 patients and establish patient-specific epileptic networks. We find that c-tDCS can suppress the propagation of abnormal activity in most patient-specific epileptic networks. However, when the PZ is widely distributed in both hemispheres, the treatment effect of c-tDCS is not satisfactory. Hence, we propose dual-cathode tDCS. For epilepsy models with a wide distribution of PZ, it can inhibit the propagation of epileptiform activity in other nodes except EZ and PZ without increasing the tDCS current strength. Our results provide theoretical support for the treatment of epilepsy with tDCS.

No comments:

Post a Comment